Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil

Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors

Salvatore Vaccarella, Joannie Lortet‐Tieulent, Martyn Plummer et al. · European Journal of Cancer · 2013 · 507 citations

Medicine, Gynecology, Oncology +16

Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women

Simon R. Dobson, Shelly McNeil, Marc Dionne et al. · JAMA · 2013 · 408 citations

Medicine, Immunology, Oncology +15

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

Sue J. Goldie, Jane J. Kim, Katie E. Kobus et al. · Vaccine · 2007 · 166 citations

Veterinary Medicine, Pharmacoeconomics, Preventive Medicine +12

Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months

Eduardo Lazcano‐Ponce, Margaret Stanley, Núbia Muñóz et al. · Vaccine · 2013 · 85 citations

Veterinary Medicine, Immunology, Pediatrics +14

Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries

Lisandro D. Colantonio, Jorge A. Gómez, Nadia Demarteau et al. · Vaccine · 2009 · 48 citations

Veterinary Medicine, Oncology, Pharmacoeconomics +16